Abstract
In 1921, Schmincke and Régaud described, independently of each other, malignant neoplasms arising from the tonsillar tissue of the nasopharynx [31, 29]. Consisting of an intimate mixture of lymphatic and carcinomatous tissue components, they were given the name of “lymphoepitheliomas.” Later, a “Schmincke” type with its dominating lymphatic component and fading epithelial strains was discerned from the “Régaud” type, showing only poor lymphatic admixture and rather resembling an anaplastic carcinoma.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albrecht R: Die Nasenrachentumoren und ihre Behandlung. Arch. Ohr.-, Nas.- u. Kehlk.-Heilk. 175 (1959) 217–221
Anderson JM, Fung JHY, Laing D: Arterial infusion chemotherapy for carcinoma of the nasopharynx. Brit. J. clin. Pract. 19 (1965) 565–567
Atzinger A, Burger G, Gflrtner H et al.: Aktueller Stand der Bestrahlungsplanung bei malignen Nasopharynxtumoren. Verh. Dtsch. Krebs-Ges. 5 (1984) 305
Bodemann HH: Chemotherapie des metastasierenden Nasopharynxkarzinoms. In Wannenmacher M (Hrsg.): Nasopharynx-Tumoren. München: Urban & Schwarzenberg 1984
Bonadonna G, Zucali R, Monfardini S et al.: Combination chemotherapy of Hodgkin’s disease with Adriamycin, Bleomycin, Vinblastine, and Imidazole Carboxamide versus MOPP. Cancer 36 (1975) 252–259
Brown AW, Blom J, Butler WM et al.: Combination chemotherapy with Vinblastine, Bleomycin and Cis-Diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck. Cancer 45 (1980) 2830–2835
Busch M, Alberti W: Optimierte Afterloading-Applikation bei Epipharynxtumoren. Strahlentherapie 160 (1984) 77–80
Carter SK: The chemotherapy of head and neck cancer. Sem. Oncol. 4 (1977) 413–424
Cortes EP, Kalra J, Amin VC et al.: Chemotherapy for head and neck cancer relapsing after radiotherapy. Cancer 47 (1981) 1966–1970
Dickson RI: Nasopharyngeal carcinoma: An Evaluation of 209 Patients. Laryngoscope 91 (1981) 333–354
Fialkow PJ, Martin GM, Klein G et al.: Evidence for a clonal origin of head and neck tumors. Int. J. Cancer 9 (1972) 133–142
Galligioni E, Carbone A, Tirelli U et al.: Combined chemotherapy with Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, and radiotherapy for advanced lymphoepithelioma. Cancer Treatm. Rep. 66 (1982) 1207–1210
Goepfert H, Moran ME, Lindberg RD et al.: Chemotherapy of advanced nasopharyngeal carcinoma (NPC). Abstract. Proc. Amer. Soc. clin. Otol. 22 (1981) 427
Ho JHC: Nasopharyngeal carcinoma (NPC). Adv. Cancer Res. 15 (1972) 57–92
Ho JHC: Nasopharynx. In Hainan KE (Edit.): Treatment of Cancer, pp. 249–267. London: Chapman and Hall 1982
Holoye PY, Byers RM, Gard DA et al.: Combination chemotherapy of head and neck cancer. Cancer 42 (1978) 1661–1669
Hoppe RT, Goffinet DR, Bagshaw MA: Carcinoma of the nasopharynx. Cancer 37 (1976) 2605–2612
Hsu MM, Huang SC, Lynn TC et al.: The survival of patients with nasopharyngeal carcinoma. Otolaryng. Head Neck Surg. 90 (1982) 289–295
Huang AT, Lucas VS, Baughn SC et al.: A trial of outpatient chemotherapy for recurrent head and neck tumors. Cancer 45 (1980) 2038–2041
Ilberg C von, Kleinmann H, Arnold W: Das Schmincke-Karzinom des Nasopharynx. Laryng. Rhinol. Otol. 55 (1976) 420–428
Jondal M, Klein G, Oldstone MBA et al.: Surface markers on human T and Blymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand. J. Immunol. 5 (1976) 401–410
Jung H: Intravitale Lymphabflußuntersuchungen vom Nasenrachendach beim Men¬schen. Laryng. Rhinol. Otol. 53 (1974) 769–773
Leipner N, Barwig P, Frommhold H: Karzinome des Nasenrachens. Laryng. Rhinol. Otol. 60 (1981)321–328
Lombardi F, Gasparini M, Gianni C et al.: Nasopharyngeal carcinoma in childhood. Med. pediat. Oncol. 10 (1982) 243–250
Maor MH, Hussey DA, Fletcher GH et al.: Fast neutron therapy for locally advanced head and neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 7 (1981) 155–169
Merino OR, Lindberg RD, Fletcher GH: An analysis of distant metastasis from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40 (1977) 145–151
Old LJ, Boyse EA, Oettgen HF et al.: Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc. nat. Acad. Sci. USA 56 (1966) 1699–1704
Presant CA, Ratkin G, Klahr C et al.: Adriamycin, BCNU plus Cyclophosphamide (ABC) in advanced carcinoma of the head and neck. Cancer 44 (1979) 1571–1575
Régaud C, Reverchon L: Sur un cas d’épithélioma épidermoide développé dans le massif maxillaire supérieur, étendu aux téguments de la face, aux cavités buccale, nasale et orbitaire, ainsi qu’aux ganglions du cou, guéri par la curiethérapie. Rev. Laryng. 42 (1921) 369–378
Schmauz R, Templeton AC: Nasopharyngeal carcinoma in Uganda. Cancer 29 (1972) 610–621
Schmincke A: Über lymphoepitheliale Geschwülste. Beitr. path. Anat. 68 (1921) 161–170
Schweisguth O: Solide Tumoren im Kindesalter. Stuttgart: Enke 1984
Sesterhenn K, Wustrow F, Bertram G: Surgical procedures in diagnosis and treatment of nasopharyngeal carcinoma — a historical review. In Grundmann E, Krueger GRF, Ablashi DV (Eds): Nasopharyngeal Carcinoma, pp.269–272. Stuttgart: Fischer 1981. ( Cancer Campaign, Vol. 5 )
Shanmugaratnam K, Sobin LH: Histological Typing of Upper Respiratory Tract Tumors. Geneva: WHO 1978. ( International Histological Classification of Tumours, No. 19 )
Simons MJ, Wee GB, Goh EH et al.: Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA-profile (A2, Singapore 2). J. nat. Cancer Inst. 57 (1976) 977–980
Snow JB: Carcinoma of the nasopharynx in children. Ann. Otol. (St. Louis) 84 (1975) 817–826
Treuner J, Niethammer D, Dannecker G et al.: Successful treatment of nasopharyngeal carcinoma with interferon. Lancet 1980, 1: 817–818
UICC (Hrsg.): TNM-Klassifikation der malignen Tumoren. 3. Aufl. Berlin: Springer 1979
Wang CC: Radiation therapy for head and neck neoplasms. Boston: Wright 1983
Wannenmacher M: Strahlentherapie der Nasopharynxcarcinome. Verh. Dtsch. Krebs- Ges. 5 (1984) 311
Waterhouse J, Muir C, Correa P et al. (Eds): Cancer Incidence in Five Continents. Vol.3. Lyon: IARC 1976. ( IARC Scientific Publications, No. 15 )
Weidauer H: Chemotherapie der malignen Nasopharynx-Tumoren. Verh. Dtsch. Krebs-Ges. 5 (1984) 333
Wilmes E, Wolf H, Deinhardt F et al.: Die Bedeutung von Epstein-Barr Virus-Antikörpern für Diagnose und Verlauf des Nasopharynxkarzinoms. Laryng. Rhinol. Otol. 58 (1979) 911–915
Wolf H, zur Hausen H, Becker V: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature NB 244 (1973) 245–247
Zeng Y, Zhang LG, Li HY et al.: Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int. J. Cancer 29 (1982) 139–141
Zeng Y, Zhong JM, Mo YK et al.: Epstein-Barr virus early antigen induction in Raji cells by Chinese medicinal herbs. Intervirology 19 (1983) 201–204
Ziegler F, Metzger H, Hübener KH: Behandlungsergebnisse beim Nasopharynxkarzinom nach Telekobalttherapie. In Wannenmacher M (Hrsg.): Nasopharynx-Tumoren. München: Urban & Schwarzenberg 1984
Zur Hausen H, Schulte-Holthausen H, Klein G et al.: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228 (1970) 1056–1058
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag
About this chapter
Cite this chapter
Vosteen, KH., Ebbers, J. (1987). Clinical Course and Therapy of Nasopharyngeal Carcinoma. In: Wagner, G., You-Hui, Z. (eds) Cancer of the Liver, Esophagus, and Nasopharynx. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71510-5_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-71510-5_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16967-3
Online ISBN: 978-3-642-71510-5
eBook Packages: Springer Book Archive